CLINICAL_TRIALS
trial_result
· 2018-05-21
Clinical Trial Update: Assess the Efficacy and Safety of ASC-01 in Patients With Major Depressive Disorder [Phase 3]
Summary
Phase 3 clinical trial results for ASC-01 in major depressive disorder were completed and results posted in May 2018.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Otsuka Pharmaceutical Co., Ltd. | Conditions: Major Depressive Disorder | Phase 3 | Status: COMPLETED | Results posted: 2018-05-21